Cerebral structure and metabolism and long-term outcome in small-for-gestational-age preterm neonates

Ariadne M Roelants-van Rijn1, Jeroen van der Grond, Robert H Stigter

  • 1Wilhelmina Children's Hospital/University Medical Center Utrecht, Department of Neonatology, Room KE 04.123.1, Lundlaan 6, 3584 EA Utrecht, The Netherlands. F.Groenendaal@WKZ.AZU.NL

Pediatric Research
|June 8, 2004
PubMed

Insights

This study found no significant differences in brain development or cerebral metabolism between small-for-gestational-age (SGA) and appropriate-for-gestational-age (AGA) infants. Neurodevelopmental outcomes at two years were also similar in both groups.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pediatric Imaging

Background:

  • Intrauterine growth restriction (IUGR) in small-for-gestational-age (SGA) infants may impact brain development and long-term neurodevelopmental outcomes.
  • Placental insufficiency is a common cause of IUGR, potentially leading to altered cerebral metabolism.
  • Early detection and understanding of brain changes in SGA infants are crucial for predicting neurodevelopmental trajectories.

Purpose of the Study:

  • To compare brain development and cerebral metabolism in preterm small-for-gestational-age (SGA) versus appropriate-for-gestational-age (AGA) infants.
  • To investigate the hypothesis that intrauterine growth retardation is associated with altered brain metabolism and adverse neurodevelopmental outcomes.
  • To assess neurodevelopmental quotients (DQ) at 2 years corrected age in relation to in-utero growth status.

Main Methods:

  • Proton magnetic resonance spectroscopy ((1)H-MRS) and magnetic resonance imaging (MRI) were used to assess brain structure and metabolism.
  • Metabolic ratios (NAA/Cho, lactate/Cho, mI/Cho, Glx/Cho) were measured in basal ganglia and periventricular white matter at 32 and 41 weeks postmenstrual age.
  • Griffiths' developmental quotient (DQ) was evaluated at 24 months corrected age.

Main Results:

  • No significant differences were observed in brain development (MRI) or cerebral metabolic ratios between SGA and AGA preterm infants.
  • Griffiths' DQ scores at 24 months corrected age did not differ significantly between the SGA and AGA groups.
  • Both groups showed developmental changes over time, with increasing NAA/Cho and decreasing mI/Cho ratios, but without intergroup differences.

Conclusions:

  • Severely SGA preterm infants did not exhibit significant differences in cerebral metabolism or brain development compared to AGA infants at term-equivalent age.
  • Neurodevelopmental outcomes at 2 years corrected age were comparable between SGA and AGA preterm infants in this cohort.
  • Intrauterine growth restriction, in the absence of major ultrasound abnormalities, did not appear to lead to detectable differences in brain metabolism or development by 2 years of age.